Low uptake limits benefits of maternal RSV vaccination
Vaccination against a common respiratory virus during pregnancy lowers the risk of severe disease in babies by 74 per cent, but uptake in many countries remains low, a new review suggests.
Read original article on The Medical News →Related news
-
UK doctors transplant frozen testicular tissue to restore fertility
United Kingdom
-
Three NHS genetics labs fail to routinely share vital variant data
United Kingdom
-
HPV vaccination may protect against adverse pregnancy outcomes
United Kingdom
-
Study highlights need for smarter, locally tailored trauma-care systems
United Kingdom
-
Hydroxyurea does not increase infection risk in children with sickle cell anemia
United Kingdom
-
Current age-based genetic testing in patients with cancer may miss the majority of inherited gene variants
United Kingdom
-
Fat-storing gene emerges as possible contributor to anorexia risk
United Kingdom
-
HPV vaccination linked to lower risk of pregnancy complications
United Kingdom